Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice
Carmelo Quarta, Kerstin Stemmer, Aaron Novikoff, et al.
Nature Metabolism (2022) Vol. 4, Iss. 8, pp. 1071-1083
Open Access | Times Cited: 22

Showing 22 citing articles:

Hawthorn carbon dots: a novel therapeutic agent for modulating body weight and hepatic lipid profiles in high-fat diet-fed mice
Shuai Lin, Y. H. Zheng, Yi Xu, et al.
Nanoscale (2025)
Closed Access
The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP
Jonathan D. Douros, Jonathan N. Flak, Patrick J. Knerr
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Discovery of Potential Inhibitors of CDK1 by Integrating Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation Studies, and Evaluation of Their Inhibitory Activity
Vineeta Teotia, Prakash Jha, Madhu Chopra
ACS Omega (2024)
Open Access | Times Cited: 3
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer
Emine Atas, Kerstin Berchtold, Michaela Schlederer, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Beneficial effects of Apelin-13 on metabolic diseases and exercise
Ruiming Wen, Ruiqi Huang, Ke Xu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Single‐Administration Self‐Boosting Microneedle Patch for the Treatment of Obesity
Parbeen Singh, Tra Vinikoor, Nidhi Sharma, et al.
Advanced Therapeutics (2024)
Closed Access | Times Cited: 3
Inter-organ cross-talk in human cancer cachexia revealed by spatial metabolomics
Na Sun, Tanja Krauss, Claudine Seeliger, et al.
Metabolism (2024), pp. 156034-156034
Open Access | Times Cited: 2
A Mitochondrion‐Targeting Piezoelectric Nanosystem for the Treatment of Erectile Dysfunction via Autophagy Regulation
Shuting Wang, Zhenqing Wang, Zhenjie Zang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 2
Peroxisome proliferator-activated receptors-alpha and gamma synergism modulate the gut-adipose tissue axis and mitigate obesity
Carolline Santos Miranda, Flávia Maria Silva-Veiga, Aline Fernandes‐da‐Silva, et al.
Molecular and Cellular Endocrinology (2022) Vol. 562, pp. 111839-111839
Open Access | Times Cited: 10
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
C. Allard, Daniela Cota, Carmelo Quarta
Drugs (2023) Vol. 84, Iss. 2, pp. 127-148
Closed Access | Times Cited: 6
Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity
Isabel Matias, Elizabeth Lehmann, Philippe Zizzari, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 5, pp. 1289-1294
Closed Access | Times Cited: 4
Bioinformatics study of the potential therapeutic effects of ginsenoside Rh3 in reversing insulin resistance
Yayun Wang, Dongming Wu, Yongxin Wang, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Poly(l-threonine-co-l-threonine Succinate) Thermogels for Sustained Release of Lixisenatide
Jin Kyung Park, Zhengyu Piao, Hyun Jung Lee, et al.
Biomacromolecules (2024) Vol. 25, Iss. 8, pp. 4946-4955
Closed Access | Times Cited: 1
Baicalein Ameliorates Insulin Resistance of HFD/STZ Mice through Activating PI3K/AKT Signal Pathway of Liver and Skeletal Muscle in a GLP-1R-Dependent Manner
Na Liu, Xin Cui, Tingli Guo, et al.
Antioxidants (2024) Vol. 13, Iss. 10, pp. 1246-1246
Open Access | Times Cited: 1
TRPV4 couples with NCX1 to mediate glucose‐dependent glucagon‐like peptide‐1 release and improve glucose homeostasis
Xiongying Chen, Fenglan Chu, Sijin Sunchen, et al.
The Journal of Physiology (2024) Vol. 602, Iss. 24, pp. 6827-6847
Closed Access | Times Cited: 1
Near-infrared remote triggering of bio-enzyme activation to control intestinal colonization by orally administered microorganisms
Wei Sun, Yun Fu, Qinglu Guo, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 1
Therapeutic Strategies Targeting Pancreatic Islet β-Cell Proliferation, Regeneration, and Replacement
Roy A Goode, Julia M. Hum, Michael A. Kalwat
Endocrinology (2022) Vol. 164, Iss. 1
Open Access | Times Cited: 6
Hepatic GCGR is required for the superior weight loss effects of a structurally related analogue of the dual GCGR/GLP1R agonist survodutide
Fen Long, Manuel Klug, Tenagne D. Challa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Facile Access to Chiral anti-1,2-Diol Derivatives via Ir-Catalyzed Asymmetric Hydrogenation of α-Alkoxy-β-Ketoesters
Yuanzheng Wang, Bin Lü, Gen‐Qiang Chen, et al.
Chemical Communications (2024)
Closed Access
Research Progress on Mechanism of Glucagon-Like Peptide-1 and Aortic Valve Calcification
盼 张
Advances in Clinical Medicine (2023) Vol. 13, Iss. 04, pp. 6439-6449
Closed Access
Who knew? PPARs may act in the brain too
Randy J. Seeley, Christopher J. Rhodes
Nature Metabolism (2022) Vol. 4, Iss. 8, pp. 965-966
Closed Access
GLP1-mediated delivery of tesaglitazar improves glucose metabolism in mice
Olivia Tysoe
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 11, pp. 657-657
Closed Access
Page 1

Scroll to top